What serious adverse reactions happened during this study?
The most common serious adverse reaction was a fever and a low level of white
blood cells called neutrophils, which is also called febrile neutropenia.
The table below shows the serious adverse reactions that happened in more
than 1 participant who took each drug during the study. There were other serious
adverse reactions, but these happened in fewer participants.
Most common serious adverse reactions
Olaparib Ceralasertib Adavosertib
(out of 265 (out of 109 (out of 46
Serious adverse reaction participants) participants) participants)
A fever and a low level of white blood cells called 1.9% (5) 0.9% (1) 10.9% (5)
neutrophils, also called febrile neutropenia
Low levels of red blood cells, also called anemia 2.3% (6) 1.8% (2) 2.2% (1)
Low levels of white blood cells called neutrophils, which 1.1% (3) 0.0% (0) 8.7% (4)
help the body fight infections
Low levels of white blood cells called leukocytes, which 0.8% (2) 0.0% (0) 4.3% (2)
help the body fight infections
Decrease in the number of platelets in the blood, which 0.8% (2) 0.9% (1) 2.2% (1)
are cells that help blood to clot
Low levels of platelets in the blood 0.4% (1) 0.0% (0) 6.5% (3)
None of the participants died because of serious adverse reactions.
13 | Clinical Study Results